Literature DB >> 10356617

[Improving prognosis by simultaneous but not sequential radiochemotherapy: results of 2 randomized studies on nasopharyngeal carcinoma].

R Fietkau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10356617     DOI： 10.1007/BF02742405

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.

Authors:  D T Chua; J S Sham; D Choy; V Lorvidhaya; Y Sumitsawan; S Thongprasert; V Vootiprux; A Cheirsilpa; T Azhar; A H Reksodiputro
Journal:  Cancer       Date:  1998-12-01       Impact factor: 6.860

2.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Authors:  M Al-Sarraf; M LeBlanc; P G Giri; K K Fu; J Cooper; T Vuong; A A Forastiere; G Adams; W A Sakr; D E Schuller; J F Ensley
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

3.  Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.

Authors: 
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-06-01       Impact factor: 7.038

4.  Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study.

Authors:  A Rossi; R Molinari; P Boracchi; M Del Vecchio; E Marubini; M Nava; L Morandi; R Zucali; S Pilotti; C Grandi
Journal:  J Clin Oncol       Date:  1988-09       Impact factor: 44.544

5.  A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.

Authors:  A T Chan; P M Teo; T W Leung; S F Leung; W Y Lee; W Yeo; P H Choi; P J Johnson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-10-15       Impact factor: 7.038
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.